{"transactions":[{"id":1568541,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Convertible Note","published_at":"2024-03-19T19:16:08.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":53500,"price":53500,"value":2862250000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a Convertible Note face $53,500.  The Note is convertible into shares of the Issuers common stock at a price of $0.02 per share."}],"balance_after":3475000,"derivative":{"exercise_price":0.02,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":2675000},"source":{"system":"sec-edgar","filing":"0001096906-24-000511","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000109690624000511/form4.xml","form_type":"4"}},{"id":2151972,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option","published_at":"2022-09-23T16:33:29.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired an option to purchase up to 500,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date."}],"balance_after":800000,"derivative":{"exercise_price":0.052,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001096906-22-002337","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000109690622002337/form4.xml","form_type":"4"}},{"id":2151971,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option","published_at":"2022-09-23T16:31:32.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":300000,"derivative":{"exercise_price":0.42,"exercise_date":"2020-12-10","expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001096906-22-002336","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000109690622002336/form4.xml","form_type":"4"}},{"id":2786200,"issuer":{"id":126275,"kind":"organization","name":"NEUROPATHIX, INC.","symbol":"NPTX"},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-16T17:02:52.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months thereafter."}],"balance_after":600000,"derivative":{"exercise_price":0.13,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001607062-21-000054","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000160706221000054/primary_doc.xml","form_type":"4"}},{"id":3159481,"issuer":{"id":126275,"kind":"organization","name":"NEUROPATHIX, INC.","symbol":"NPTX"},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T21:43:25.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months commencing with the\nvesting commencement date of January 1, 2020."}],"balance_after":300000,"derivative":{"exercise_price":0.57,"expiration_date":"2030-05-03","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001683168-20-001429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000168316820001429/ownership.xml","form_type":"4"}},{"id":3159480,"issuer":{"id":126275,"kind":"organization","name":"NEUROPATHIX, INC.","symbol":"NPTX"},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T21:38:01.000Z","date":"2019-08-14","kind":"grant","acquired":true,"shares":250000,"price":0.1,"value":25000.0,"ownership":{"direct":true},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001683168-20-001423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000168316820001423/ownership.xml","form_type":"4"}},{"id":3967681,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2018-04-06T15:35:47.000Z","date":"2018-03-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001078782-18-000415","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000107878218000415/primary_doc.xml","form_type":"4"}}]}